Clinical Trial Update: Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors

View source ↗

Summary

Clinical trial update describing a basic study of a combination therapy based on APCC-induced activation of Factor VIII in Hemophilia A patients with inhibitors…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Activated Prothrombin Complex Concentrate (APCC) (activated prothrombin complex concentrate)

Snippet

Sponsor: Nara Medical University | Conditions: Hemophilia A With Inhibitor | Status: UNKNOWN